Data Snapshot: Nov 03, 2026
<$50K

Oct-2026

Sales

Strong Growth

Trend

6-Month

11

Product Count

SKUs

$34.66

Avg Price

-14%

YoY Sales Change

3.6%

YoY Price Change

"Kind Medicine" is a prominent brand in the medical marijuana and adult-use cannabis sector, known for its scientifically backed and FDA-approved THC-based products. The brand, operating legally under licenses issued by the Cannabis Regulatory Commission, secures cannabis through dispensing organizations. With a strong commitment to the medical benefits of cannabis, "Kind Medicine" continually engages in cannabis-related research and provides comprehensive patient information resources.
How loyal are cannabis customers to the brands they buy? See retention benchmarks by category and state →
For brands

Is this your brand?

See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.

See your brand's data
For retailers

Carry this brand in your store?

Headset Retailer is free. Connect your POS and see what's selling and what's sitting.

Sign up free
Kind Medicine Sales

Market Insights Snapshot

Kind Medicine Historical Sales by Category

In October 2026, Kind Medicine concentrated 83.60% of sales in Tincture & Sublingual, where category sales rose 12.61% year over year and 11.80% month over month, while the brand’s overall sales fell 13.98% YoY and average price rose 3.62%. Capsules shrank to 9.72% share with a 68.79% YoY decline and a 27.99% MoM drop, and Topical held 6.68% share with a 38.52% YoY decline and a 57.74% MoM contraction. With Tincture & Sublingual ranked 19th in California and commanding the mix, the pattern implies Kind Medicine is consolidating around one category while retreating from Capsules and Topical, trading breadth for depth.

The surge in Tincture & Sublingual alongside steep declines in Capsules and Topical indicates a deliberate pivot toward higher-velocity formats at a mid-tier price point ($34.24 average in Tincture & Sublingual vs. $50.67 in Capsules), suggesting price-sensitive demand capture and a repositioning away from premium encapsulated offerings. Given 24‑month sales down 2.56% and the October rank of 19 in Tincture & Sublingual in California, the mix shift implies Kind Medicine is aiming for sustained shelf presence through category focus rather than multi-category expansion, accepting lower category diversification to stabilize velocity and defend rank.

Oct-2026 Rank
Tincture & Sublingual
#19
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Tincture & Sublingual
83.6%
$34.24
+12.6%
+11.8%
Capsules
9.7%
$50.67
-68.8%
-28.0%
Topical
6.7%
$26.54
-38.5%
-57.7%
Kind Medicine

Competitive Landscape

Kind Medicine sits at rank 19 in California Tincture & Sublingual for October 2026, unchanged year over year at 19 while slipping 1 place from July 2026’s rank 18; against its historical context, the brand is 3 spots below its peak rank 16 from April 2025 and thus 19% farther from the top-10 threshold than at that peak. Competitive momentum is moving around it: Papa & Barkley holds rank 1 with an 8.27% year-over-year sales increase, while Yummi Karma is at rank 2 with a 20.79% year-over-year sales increase, and Mary's Medicinals climbed from rank 7 to rank 4 on 58.13% year-over-year growth. In contrast, Care By Design fell from rank 3 to rank 5 alongside a 35.91% year-over-year sales decline, and VET CBD improved from rank 4 to rank 3 despite a 4.35% year-over-year sales contraction, signaling that flat rank at 19 amid upward and downward shifts nearby implies Kind Medicine’s share is being diluted by faster-moving leaders and volatility above it rather than by direct head-to-head displacement in the teens.

Kind Medicine category ranking vs. nearest competitors
Kind Medicine

Notable Products

Kind Medicine is concentrated in tinctures, with Tincture accounting for 83.6% of October 2026 sales and the top 10 items covering 99.3% of the lineup’s revenue. Indica Tincture (800mg THC,30ml) alone holds 25.1%, so most of its sales ride on a few tincture SKUs.

Product
Type
Share of Sales
Avg Price
vs. Peer Avg
MoM %
Indica Tincture (800mg THC,30ml)
Tincture
25.1%
$33.98
-2.2%
+80.9%
Sativa Tincture (800mg THC, 30ml)
Tincture
24.0%
$35.60
+2.4%
+35.5%
Indica Tincture (1000mg THC,30ml)
Tincture
15.3%
$31.82
+1.3%
+18.5%
Indica Capsules 32-Pack (960mg)
Indica
8.3%
$57.90
+0.0%
-4.1%
CBD/THC 25:1 Pet Tincture (500mg CBD, 20mg THC, 30ml)
Tincture
8.2%
$36.55
+5.7%
-46.4%
Menthol Formula Rub (150mg THC, 50ml)
Lotion, Salves, Gels, and Creams
5.8%
$25.86
-59.9%
+36.1%
CBD Clarity Tincture (1000mg CBD, 30ml)
Tincture
5.6%
$34.78
—
-42.7%
Sativa Tincture (1000mg THC, 30ml)
Tincture
5.3%
$33.16
+5.5%
+3.8%
CBD/THC 1:1 Kind Rub Moisture Roll-On (37.5mg CBD, 37.5mg THC, 25ml)
Lotion, Salves, Gels, and Creams
0.9%
$31.99
+0.0%
-83.2%
Indica Capsules 10-Pack (300mg)
Indica
0.7%
$28.96
+0.0%
-56.8%

Peer avg: average price of the same product type and package size in the same states that month.

View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market